Additionally, expression of chemokines i.e. CCL5 (p = 5.55e−016), CCL7 (p = 1.47e−011), CCL8 (p = 1.9e−11), CCL20 (p = 1.37e−010), and CCL25 (p = < 0.00001) were highest in the basal BrCa subtype, when compared to luminal A/B and HER2 status. This evidence concerns the gene CCL25 and invasive breast carcinoma.